Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Randomization Upon evaluating 100 prospective participants for eligibility, 56 individuals were rendered ineligible due to their failure to meet the predetermined exclusion criteria
Scientific rigor translates into profound benefits for patients, with data indicating the potential to lose up to 26%+ of initial body weight over 6-8 weeks.* *Results may vary
Some patients experience a weight loss plateau after several months at their maintenance dose, which is a normal biological response rather than a sign that semaglutide has stopped working
Evernorth is guaranteeing a maximum 15% annual increase in spend
The entry of multiple manufacturers and sellers into the market should mean lower drug prices and greater patient access
Inflammatory bowel syndrome Stomach ulcers Bone fractures Injured ligaments, nerves, and muscles Tendinopathies (tendon injuries) like tennis or golf elbow, trigger fingers, or Achilles tendinitis Ulcerative colitis (short bowel syndrome, anastomosis, and fistula) Perforated cecum (part of the large intestine) Post-surgery recovery Spinal cord injuries Arrhythmia (irregular heartbeat) Periodontitis (gum damage) The outcomes for rats may differ from those for humans
